GE Healthcare partners with Vanderbilt University to create AI apps

US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence (AI).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

GE to sell biopharma unit to Danaher for $21.4 billion

28 February 2019 General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.

Big Pharma

Novartis enters AI partnership with Oxford University

21 January 2019 Novartis and the University of Oxford’s Big Data Institute have joined forces to use artificial intelligence for improving drug development, initially in the areas of multiple sclerosis, dermatology and rheumatology.

Americas

GE Healthcare files patent lawsuit against Bio-Rad

5 December 2018 American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

More features

AIPPI: Personalised medicine tests the limits in patent law

Ropes & Gray loses 21-attorney group to join rival on growth spree

How 'Boehringer' sets preliminary relief threshold for generics

‘Whose trademark law is AI based on exactly?’: Key questions from Marques

The Quintara decision: Defining trade secrets in federal cases

To disclose or not: Pharma patents face new AI reality

Trade secrets go global: How brand owners face a high-stakes battlefront

Killing the golden goose of US drug innovation (Part II): Drug pricing myths

GE Healthcare partners with Vanderbilt University to create AI apps

More on this story

Editor's picks

Editor's picks

More features